COMMUNIQUÉS West-GlobeNewswire

Algernon Pharmaceuticals Announces Private Placement
11/07/2024
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: [...]
AVITA Medical to Announce Second Quarter 2024 Financial Results
11/07/2024
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
11/07/2024
This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. UPPSALA, Sweden, July 11, 2024 (GLOBE NEWSWIRE) -- The [...]
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
11/07/2024
SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food [...]
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
11/07/2024
STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the second quarter [...]
Elutia to Present at the Emerging Growth Conference on Thursday, July 18
11/07/2024
SILVER SPRING, Md., July 11, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, [...]
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
11/07/2024
SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
11/07/2024
DENVER, July 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that it has closed its previously announced registered offering for the issuance and sale of an [...]
Oncternal Therapeutics to Present in JonesTrading Healthcare Summit
11/07/2024
SAN DIEGO, July 11, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that James [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
11/07/2024
BOSTON, July 11, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]
Spectral Medical Inc. Announces Change to Auditor
11/07/2024
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company" ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced [...]
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
11/07/2024
Presented positive clinical data at the European Hematology Association Congress supporting a potential best-in-class profile for NX-5948 for the treatment of CLL Strengthened leadership with appointment of Paula G. O’ [...]
Derek Chaves nommé Directeur financier de Corza Medical
11/07/2024
WESTWOOD, Massachusetts, 11 juill. 2024 (GLOBE NEWSWIRE) -- Corza Medical (« Corza » ou la « Société ») est fière d’annoncer la nomination de Derek Chaves au poste de Directeur financier (CFO) de l’entreprise, à compter [...]
Pennant Announces Agreement to Purchase the Assets of Signature Healthcare at Home
11/07/2024
EAGLE, Idaho, July 11, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it has [...]
ESP prostheses training program
11/07/2024
Press release Ecully, July 11, 2024 – 6.30 p.m. Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in Strasbourg The Spineway Group, a specialist in innovative implants for [...]
Programme de formation prothèses ESP
11/07/2024
Communiqué de presse Ecully, le 11 juillet 2024 – 18h30 Spineway organise une formation pratique à l’IRCAD de Strasbourg sur le remplacement total de disque avec ses prothèses ESP Le groupe Spineway, spécialiste des [...]
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
11/07/2024
WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]
Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer
11/07/2024
Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in preclinical models of [...]
Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024
11/07/2024
Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Leuven, BELGIUM – July 11, 2024 – 6:00pm CET – Oxurion NV (Euronext Brussels: OXUR), an [...]

Pages